Stockholders' Deficiency (Details Narrative) - USD ($)		1 Months Ended		12 Months Ended
	Apr. 03, 2015	Jul. 28, 2016	Aug. 25, 2014	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016	Jan. 03, 2016	Dec. 21, 2015	Oct. 17, 2011
Common stock, par value				$ 0.001	$ 0.001
Common stock, authorized				100,000,000	100,000,000
Preferred stock, par value				$ 0.001	$ 0.001
Preferred stock, authorized				1,000,000	1,000,000
Series A Convertible preferred stock, shares designated				200,000	200,000
Series A Convertible preferred stock, shares available to be issued				44,443	44,443
Series A Convertible preferred stock, shares outstanding				0	0
Series B Convertible preferred stock, shares designated				625,000	625,000
Redeemable preferred stock Series C, par value				0.001	0.001
Redeemable preferred stock Series C, shares designated				10,000	10,000
Common stock purchased				2,141,339
Selling, General And Administrative Expenses				$ 327,202	$ 308,026
Stock-based compensation expense, unamortized				$ 327,202	$ 320,366
Weighted Average Remaining Period				1 year 6 months
Weighted Average Annual Rate				5.00%	3.00%
Stock-based compensation expense				$ 36,291
Proceeds from allocation of preferred stock				$ 3,199,689
Issuance of series B preferred stock				422,315
Per share price of series B preferred stock				$ 9.45
Net debt due to series B preferred stock				$ 1,000,000
Options term				10 years
Options vesting period, minimum				0 years
Options vesting period, maximum				3 years
Consultants [Member]
Common stock purchased					349,861
Selling, General And Administrative Expenses					$ 322
Employees And Directors [Member]
Common stock purchased					2,141,339
Series C Preferred Stock [Member]
Shares issued									10,000
Shares issued value									$ 1,000,000
Series B Preferred Stock [Member]
Preferred stock, par value							$ 0.66
Preferred Stock, Dividend Rate, Percentage				7.00%
Incremental shares value				$ 8,696,723
Common stock issuable				3,445,611
Converted shares				11.66	11.39
Shares issued							33,847
Shares issued value							$ 320,000
Accrual of contractual dividends on Series B convertible preferred stock				$ 342,233	$ 319,853
Dellave Holdings LLC [Member]
Shares issued		2,253,528
Extinguishment of accounts payable		$ 698,594
Closing price		$ 0.31
Aggregate grant date value		$ 698,594
Former Employee [Member]
Shares issued								94,779
Warrants to purchase to purchase common shares	137,430
Exercise price	$ 0.09
Aggregate grant date value	$ 12,018
directors, employees, and consultants [Member]
Common stock purchased				660,265
Minimum [Member] | Consultants [Member]
Weighted Average Fair Value					$ 0.09
Minimum [Member] | Employees And Directors [Member]
Weighted Average Fair Value					0.09
Minimum [Member] | Former Employee [Member]
Weighted Average Fair Value	$ 0.25
Minimum [Member] | directors, employees, and consultants [Member]
Weighted Average Fair Value				$ 0.24
Maximum [Member] | Consultants [Member]
Weighted Average Fair Value					0.12
Maximum [Member] | Employees And Directors [Member]
Weighted Average Fair Value					$ 0.15
Maximum [Member] | Former Employee [Member]
Weighted Average Fair Value	$ 0.09
Maximum [Member] | directors, employees, and consultants [Member]
Weighted Average Fair Value				$ 0.35
Warrant [Member]
Shares issued				1,155,179	97,449
Warrants to purchase to purchase common shares				1,795,080	137,430
Exercise price					$ 0.09
Intrinsic value of the warrants exercised				$ 414,176
Stock option exercise price				$ 0.30
Proceeds from allocation of preferred stock				$ 791,188
Issuance of series B preferred stock				365,265
Beneficial conversion feature				$ 1,666,967
Warrant [Member] | Minimum [Member]
Stock option exercise price						$ 0.10
Warrant [Member] | Maximum [Member]
Stock option exercise price						0.15
Stock Option [Member]
Shares issued				1,492,078
Weighted Average Fair Value					$ 0.10
Aggregate shares of Common Stock				1,492,078
Exercise options to purchase				16,666
Exercise options to proceeds				$ 1,833
Stock option exercise price				$ 0.76
Stock Option [Member] | Minimum [Member]
Weighted average forfeited shares				3.00%	3.00%
Weighted Average Fair Value				$ 0.09	$ 0.30
Intrinsic value of the options exercised				$ 480,041
Stock option exercise price						$ 0.09
2014 Equity Incentive Plan [Member]
Common stock, authorized			6,000,000
Maximum shares issuable			1,500,000
Maximum shares issuable without subject to performance			$ 1,200,000
Common stock issuable			6,000,000
Incentive Compensation / Stock Option Plans [Member]
Maximum shares issuable				250,000
Amount paid out as performance units in any 12-month performance period				$ 2,000,000
Amount paid out as performance units greater than 12-month performance period				$ 4,000,000
Common stock issuable				2,881,425